Biotechnology in the United Kingdom
Summary
Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
- The UK biotechnology market recorded revenues of $120.0 billion in 2024, representing a compound annual growth rate (CAGR) of 3.1% between 2019 and 2024.
- The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $84.5 billion, equivalent to 70.4% of the market's overall value.
- The UK biotechnology market is experiencing unprecedented growth, fueled by a surge in equity financing and venture capital investments.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts
- What was the size of the United Kingdom biotechnology market by value in 2024?
- What will be the size of the United Kingdom biotechnology market in 2029?
- What factors are affecting the strength of competition in the United Kingdom biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up the United Kingdom's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the key players?
- 7.2. What strategies do the key players follow?
- 7.3. What have been the most recent market developments?
- 8 Company Profiles
- 8.1. AstraZeneca Plc
- 8.2. GSK plc
- 8.3. Oxford Nanopore Technologies Plc
- 8.4. Immunocore Holdings Plc
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: United Kingdom biotechnology industry value: $ million, 2019-24
- Table 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2019-24
- Table 3: United Kingdom biotechnology industry category segmentation: $ million, 2019-24
- Table 4: United Kingdom biotechnology industry geography segmentation: $ million, 2024
- Table 5: United Kingdom biotechnology industry value forecast: $ million, 2024-29
- Table 6: AstraZeneca Plc: Key Facts
- Table 7: AstraZeneca Plc: Annual Financial Ratios
- Table 8: AstraZeneca Plc: Key Employees
- Table 9: GSK plc: Key Facts
- Table 10: GSK plc: Annual Financial Ratios
- Table 11: GSK plc: Key Employees
- Table 12: Oxford Nanopore Technologies Plc: Key Facts
- Table 13: Oxford Nanopore Technologies Plc: Annual Financial Ratios
- Table 14: Oxford Nanopore Technologies Plc: Key Employees
- Table 15: Oxford Nanopore Technologies Plc: Key Employees Continued
- Table 16: Immunocore Holdings Plc: Key Facts
- Table 17: Immunocore Holdings Plc: Annual Financial Ratios
- Table 18: Immunocore Holdings Plc: Key Employees
- Table 19: United Kingdom Size of Population (Million), 2019-24
- Table 20: United Kingdom Real GDP (Constant 2010 Prices, $ Billion), 2019-24
- Table 21: United Kingdom GDP (Current Prices, $ Billion), 2019-24
- Table 22: United Kingdom Inflation, 2019-24
- Table 23: United Kingdom Consumer Price Index (Absolute), 2019-24
- Table 24: United Kingdom Exchange Rate, 2019-24
- List of Figures
- Figure 1: United Kingdom biotechnology industry value: $ million, 2019-24
- Figure 2: United Kingdom biotechnology industry category segmentation: $ million, 2019-24
- Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2024
- Figure 4: United Kingdom biotechnology industry value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2024
- Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2024
- Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2024
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2024
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook